Cochlear implantation for single-sided deafness after COVID-19 hospitalization.
Cochlear Implants Int
; 22(6): 353-357, 2021 11.
Article
in English
| MEDLINE | ID: covidwho-1272924
ABSTRACT
INTRODUCTION:
Understanding the clinical manifestations of the coronavirus disease (COVID-19) has become an urgent objective in the research community. Amongst the emerging neurologic complications is sensorineural hearing loss. While several cases of hearing loss amongst COVID-19 patients have been reported, the management of these patients has yet to be discussed and determined. Herein we present cochlear implant outcomes for a patient who suffered from unilateral sensorineural hearing loss after a prolonged hospital course for COVID-19.METHODS:
A patient who was hospitalized for COVID-19 for one month and subsequently developed unilateral profound sensorineural hearing loss underwent cochlear implantation for single-sided deafness. His COVID-19 hospital course was reviewed in detail. Speech perception and audiometric assessments were used to evaluate cochlear implant outcomes.RESULTS:
After cochlear implantation, the patient demonstrated improved speech perception on the implanted side and decreased tinnitus within 1 month of activation.CONCLUSIONS:
Cochlear implantation may be an appropriate intervention for patients who suffer from severe sensorineural hearing loss following infection with COVID-19.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Cochlear Implantation
/
Deafness
/
Hearing Loss, Unilateral
/
COVID-19
Type of study:
Experimental Studies
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
Cochlear Implants Int
Journal subject:
Audiology
Year:
2021
Document Type:
Article
Affiliation country:
14670100.2021.1936364
Similar
MEDLINE
...
LILACS
LIS